vimarsana.com
Home
Live Updates
Trial Evaluates Reduced Chemo Post-Stem Cell Transplant in Blood Cancers : vimarsana.com
Trial Evaluates Reduced Chemo Post-Stem Cell Transplant in Blood Cancers
The first patient has been enrolled in a clinical trial evaluating a reduced dose of post-transplant immunosuppressive chemotherapy cyclophosphamide for patients with blood cancers.
Related Keywords
United States ,
Oregon ,
Jefferyj Auletta ,
Rachelj Cook ,
,
International Blood ,
Science University ,
National Marrow Donor Program ,
Marrow Transplant Research ,
Oregon Health ,
National Marrow Donor ,
Clinical Trial Corner ,
Aml ,
Mds ,
vimarsana.com © 2020. All Rights Reserved.